197 related articles for article (PubMed ID: 19937420)
1. Upper gastrointestinal promotility drugs: not all uniform?
Brun R; Kuo B
Indian J Gastroenterol; 2009; 28(4):123-5. PubMed ID: 19937420
[No Abstract] [Full Text] [Related]
2. [Prokinetic drugs in gastroenterology].
Galmiche JP; Bruley des Varannes S; Le Bodic L
Gastroenterol Clin Biol; 1991; 15(2 ( Pt 3)):T7-10. PubMed ID: 2065903
[No Abstract] [Full Text] [Related]
3. Ion channels as targets for treatment of gastrointestinal motility disorders.
Farrugia G
Eur Rev Med Pharmacol Sci; 2008 Aug; 12 Suppl 1():135. PubMed ID: 18924455
[No Abstract] [Full Text] [Related]
4. Pharmacology of the new treatments for lower gastrointestinal motility disorders and irritable bowel syndrome.
Camilleri M
Clin Pharmacol Ther; 2012 Jan; 91(1):44-59. PubMed ID: 22071696
[No Abstract] [Full Text] [Related]
5. Drugs targeting functional bowel disorders: insights from animal studies.
Sanger GJ; Hicks GA
Curr Opin Pharmacol; 2002 Dec; 2(6):678-83. PubMed ID: 12482730
[TBL] [Abstract][Full Text] [Related]
6. 5-HT receptors and visceral hypersensitivity - 2B or not 2B, that is the question?
Grundy D
Neurogastroenterol Motil; 2006 May; 18(5):339-42. PubMed ID: 16629859
[No Abstract] [Full Text] [Related]
7. [Prokinetic agents (prokinetics) in the treatment of motor disorders of the gastrointestinal tract].
Frol'kis AV
Ter Arkh; 1998; 70(2):69-72. PubMed ID: 9551580
[No Abstract] [Full Text] [Related]
8. Prokinetic agents in the surgical patient.
Thompson JS; Quigley EM
Am J Surg; 1999 Jun; 177(6):508-14. PubMed ID: 10414704
[No Abstract] [Full Text] [Related]
9. [Motility-modifying drugs].
Storr M; Allescher HD
Internist (Berl); 2000 Dec; 41(12):1318-24, 1326-30. PubMed ID: 11189067
[No Abstract] [Full Text] [Related]
10. Interstitial cells of Cajal as targets for pharmacological intervention in gastrointestinal motor disorders.
Huizinga JD; Thuneberg L; Vanderwinden JM; Rumessen JJ
Trends Pharmacol Sci; 1997 Oct; 18(10):393-403. PubMed ID: 9357324
[TBL] [Abstract][Full Text] [Related]
11. Basic and clinical pharmacology of new motility promoting agents.
Galligan JJ; Vanner S
Neurogastroenterol Motil; 2005 Oct; 17(5):643-53. PubMed ID: 16185302
[TBL] [Abstract][Full Text] [Related]
12. Are We Close to Targeting Enteric Glia in Gastrointestinal Diseases and Motility Disorders?
Gulbransen BD; Christofi FL
Gastroenterology; 2018 Aug; 155(2):245-251. PubMed ID: 29964042
[No Abstract] [Full Text] [Related]
13. Prokinetics and fundic relaxants in upper functional GI disorders.
Tack J
Curr Opin Pharmacol; 2008 Dec; 8(6):690-6. PubMed ID: 18940266
[TBL] [Abstract][Full Text] [Related]
14. Moving ahead or falling behind?
Hanauer SB
Nat Clin Pract Gastroenterol Hepatol; 2007 Jun; 4(6):295. PubMed ID: 17541443
[No Abstract] [Full Text] [Related]
15. [The pharmacological basis of the treatment of disorders of gastrointestinal motility].
Vantrappen G; Hellemans J; Janssens J
Acta Gastroenterol Belg; 1967 Oct; 30(10):646-58. PubMed ID: 5594398
[No Abstract] [Full Text] [Related]
16. [Gastrointestinal motility disorders and drugs: opioids, calcium antagonists, nitrates, peptides, prostaglandins and 5-hydroxytryptaminergic drugs (part II)].
Jovanović-Mićić D; Samardzić R; Beleslin B
Srp Arh Celok Lek; 1994; 122(3-4):88-92. PubMed ID: 17972818
[TBL] [Abstract][Full Text] [Related]
17. Gastrointestinal motility disorders and gastrointestinal prokinetic therapy.
Washabau RJ
Vet Clin North Am Small Anim Pract; 2003 Sep; 33(5):1007-28, vi. PubMed ID: 14552159
[TBL] [Abstract][Full Text] [Related]
18. Tachykinin receptors as drug targets for motility disorders.
Hoogerwerf WA; Sarna SK
Dig Dis; 2006; 24(1-2):83-90. PubMed ID: 16699266
[TBL] [Abstract][Full Text] [Related]
19. New pharmacologic therapies in gastrointestinal disease.
Wallace JL; Ferraz JG
Gastroenterol Clin North Am; 2010 Sep; 39(3):709-20. PubMed ID: 20951926
[TBL] [Abstract][Full Text] [Related]
20. Current Challenges and Emerging Solutions in Upper GI Disorders: A Brief Report of the 2016 AGA Drug Development Conference.
Howden CW; Vakil NB
Gastroenterology; 2017 Mar; 152(4):e1-e4. PubMed ID: 28147223
[No Abstract] [Full Text] [Related]
[Next] [New Search]
